# Artefill for the Treatment of HIV-associated Facial Lipoatrophy

> **NCT02009462** · PHASE1 · COMPLETED · sponsor: **Gerald Pierone, Jr. M.D.** · enrollment: 31 (actual)

## Conditions studied

- HIV-facial Lipoatrophy

## Interventions

- **DRUG:** Artefill dermal filler

## Key facts

- **NCT ID:** NCT02009462
- **Lead sponsor:** Gerald Pierone, Jr. M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02009462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02009462, "Artefill for the Treatment of HIV-associated Facial Lipoatrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02009462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*